CODX - コ・ダイアグノスティックス (Co-Diagnostics Inc.)


   Co-Diagnostics stock rises as coronavirus escalates  2020/03/11 15:07:15 Yahoo Finance
Co-Diagnostics stocks rose as investors believe the company will be able to release a vaccine for the coronavirus. Yahoo Finance’s Alexis Christoforous joins the On The Move panel to discuss how the health companies are responding to the coronavirus.
   The Zacks Analyst Blog Highlights: Buckle, Chipotle Mexican Grill, Co-Diagnostics, Moderna and Regeneron Pharmaceuticals  2020/03/11 13:09:00 Zacks Investment Research
The Zacks Analyst Blog Highlights: Buckle, Chipotle Mexican Grill, Co-Diagnostics, Moderna and Regeneron Pharmaceuticals
   Co-Diagnostics down 39% on proliferation of COVID-19 competitors  2020/03/10 18:10:02 Seeking Alpha
Co-Diagnostics (CODX -38.9%) represents a shining example of the risks in playing a highly volatile stock amid market turmoil related to COVID-19. Shares a
   Co-Diagnostics Sees Strong Demand for Its Coronavirus Kits  2020/03/05 17:00:45 The Street
Co-Diagnostics reports strong global demand for its coronavirus detection kits.
   Co-Diagnostics Says COVID-19 Test Kit Demand Surges In Recent Weeks  2020/03/05 13:40:09 Benzinga
Co-Diagnostics Inc (NASDAQ: CODX ) shares have been on a roll following the outbreak the COVID-19 , the latest coronavirus strain that has stirred fears and anxiety. Shares received another boost Thursday following disclosure from the company that its COVID-19 test kit demand remains robust. The molecular diagnostics company that uses a patented platform for the development of diagnostic tests said demand, both domestic and international, surged for its COVID-19 detection kits in recent weeks, leading to increased product shipments. The increase comes after the FDA changed its policy Feb. 20 and the … Full story available on
   Co-Diagnostics Inc to Discuss New Coronavirus Test During GenomeWeb Webinar on Feb 5  2020/02/04 11:30:00 Business Wire
SALT LAKE CITY,--(BUSINESS WIRE)---- $CODX #GenomeWeb--Co-Diagnostics Inc to discuss new coronavirus test during GenomeWebinar on Feb 5, as well as multiplex applications for vector control solutions
   Co-Diagnostics Inc CEO Discusses Novel Coronavirus with CNBC Squawk Box Asia  2020/01/28 11:30:00 Business Wire
SALT LAKE CITY--(BUSINESS WIRE)---- $CODX #Biotech--Co-Diagnostics CEO discusses novel coronavirus with CNBC Squawk Box Asia, including importance of accurate diagnostics and test announced last week
   Co-Diagnostics launches $5M direct offering; shares down 16% premarket  2020/01/24 13:33:41 Seeking Alpha
Co-Diagnostics (NASDAQ:CODX) has entered into definitive agreements with institutional investors for the purchase of 3,448,278 common shares at $1.45 per s
   Co-Diagnostics Announces $5.0 Million Registered Direct Offering Priced At-the-Market  2020/01/24 13:00:00 Business Wire
SALT LAKE CITY--(BUSINESS WIRE)---- $CODX #CODX--Co-Diagnostics announces $5.0 Million registered direct offering, following news about beginning work on a test for the new coronavirus.
   Co-Diagnostics Rallies On Plans To Develop Screening Test For Coronavirus  2020/01/23 13:37:53 Benzinga
Shares of molecular diagnostic company Co-Diagnostics Inc (NASDAQ: CODX ) are riding high on the Wuhan coronavirus wave, at their highest level in about a year. The Utah-based company said it has completed principle design work for a PCR screening test for the new coronavirus, 2019-nCoV, which will potentially detect the virus. Co-Diagnostics said the new test uses its patented CoPrimer technology and was designed to use its proprietary software system. The test would follow the guidelines published by the World Health Organization and Centers for Disease Control, the company added. See Also: The Daily Biotech Pulse: … Full story available on
  Co-Diagnostics、Inc.は、EEEウイルスのベクターコントロールモスキートテストを開始します」 Co-Diagnostics, Inc. Launches Vector Control Mosquito Test for EEE Virus  2019/12/10 11:30:00 Business Wire
「ソルトレイクシティ-(BUSINESS WIRE)-(ビジネスワイヤ)-Co-Diagnosticsは、EEEのベクターコントロールテストを開始し、致命的な東部馬脳炎ウイルスを媒介する蚊に対する予防的な防御を提供します
SALT LAKE CITY--(BUSINESS WIRE)--Co-Diagnostics launches vector control test for EEE, providing proactive defense against mosquitoes carrying deadly eastern equine encephalitis virus
   Co-Diagnostics, Inc. Reports Continued Sales Momentum for Q3 2019  2019/11/13 11:30:00 Business Wire
Revenue includes sales of infectious disease, mosquito abatement products and AgBio primer design services
   Market Sentiment Around Loss-Making Co-Diagnostics, Inc. (NASDAQ:CODX)  2019/08/02 13:02:43 Yahoo Finance
Co-Diagnostics, Inc.'s (NASDAQ:CODX): Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture…
   FDA OKs first Zika diagnostic test in U.S.  2019/05/24 14:28:47 Seeking Alpha
   Catalyst Pharmaceuticals and Genetic Technologies among healthcare gainers; ImmunoGen leads the losers  2019/05/15 15:01:36 Seeking Alpha